A phase III, randomized, non-inferiority study comparing the efficacy and safety of biosimilar filgrastim versus originator filgrastim for chemotherapy-induced neutropenia in breast cancer patients
Titel:
A phase III, randomized, non-inferiority study comparing the efficacy and safety of biosimilar filgrastim versus originator filgrastim for chemotherapy-induced neutropenia in breast cancer patients
Auteur:
Hegg, Roberto Mattar, André de Matos Neto, João Nunes Pedrini, José Luiz Aleixo, Sabina Bandeira Rocha, Roberto Odebrecht Cramer Junior, Renato Peixoto van-Eyll-Rocha, Sylvie